Martin Shkreli

Martin Shkreli is an American businessman and former pharmaceutical executive, known for his controversial actions in the healthcare industry. In 2015, he gained notoriety for drastically raising the price of a life-saving drug called Daraprim by over 5,000%, which sparked outrage and debate about pharmaceutical pricing practices. Shkreli was later convicted of securities fraud in 2017 for misleading investors and was sentenced to prison. His actions highlighted broader issues related to drug pricing, ethics in healthcare, and corporate responsibility, making him a polarizing figure in discussions about the pharmaceutical industry.